Congenital rubella syndrome in a child born to Liberian refugees: Clinical and public health perspectives

Clinical Pediatrics

Volumn 46, Issue 4, 2007, Pages 349-355

  Plotinsky, Rachel N ^a,e   Talbot, Elizabeth A ^a,b,c   Kellenberg, Joan E ^d   Reef, Susan E ^f   Buseman, Sandra K ^d   Wright, Karen D ^c   Modlin, John F ^b,c  

^a Department of Health and Human Services ^*  (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d Manchester Health Department   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

Congenital rubella syndrome; Refugee; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; CASE REPORT; CHILDBIRTH; CLINICAL ASSESSMENT; CONGENITAL RUBELLA SYNDROME; CONGESTIVE HEART FAILURE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GESTATIONAL AGE; HEARING IMPAIRMENT; HEART LEFT RIGHT SHUNT; HEART MURMUR; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LIBERIA; LYMPHADENOPATHY; MACULOPAPULAR RASH; PATENT DUCTUS ARTERIOSUS; PNEUMONIA; PUBLIC HEALTH; REFUGEE; RUBELLA VIRUS; UNITED STATES; VIRUS CULTURE; VIRUS IMMUNITY; WILD TYPE;

AFRICAN CONTINENTAL ANCESTRY GROUP; CONTACT TRACING; FEMALE; HUMANS; INFANT, NEWBORN; LIBERIA; NEW HAMPSHIRE; PUBLIC HEALTH; REFUGEES; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE;

EID: 34247256812     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922806293915     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Achievements in public health: elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Morb Mortal Wkly Rep. 2005 ; 54: 1-4.
2. Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Atlanta, GA: US Department of Health and Human Services, CDC ; 2002: 12-1-12.
3. World Health Organization. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec. 2005: 14 ; 126-132.
4. Council of State and Territorial Epidemiologists (CSTE). 1999 position statement ID-4. Presented at the CSTE National Meeting, Madison, WI, 1999. Available at: http://www.cste.org/ps/1999/1999-id-04.htm. Accessed November 23, 2005.
5. Centers for Disease Control and Prevention. Global measles and rubella laboratory network, January 2004-June 2005. MMWR Morb Mortal Wkly Rep. 2005 ; 54: 1100-1104.
6. Cooper LZ, Alford Jr CA Rubella. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 5 th ed. Philadelphia, PA: W.B. Saunders Company ; 2001 ; 348-371.
7. Miller E., Cradock-Watson JE, Pollack, TM Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982 ; 2: 781.
8. Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Morb Mortal Wkly Rep. 2001 ; 50 (No. RR- 12). 1-23.
9. Cooper LZ, Krugman S. Diagnosis and management: congenital rubella. Pediatrics. 1966 ; 37: 335-338.
10. Cradock-Watson JE, Ridehalgh Mks, Chantler S. Specific immunoglobulins in infants with the congenital rubella syndrome. J Hyg (Lond). 1976 ; 76: 109-123.
11. Horstmann D. Rubella: the challenge of its control. J Infect Dis. 1971: 123 ; 640-654.
12. Gershon A. Rubella (German measles). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol 2, 5 th ed. Philadelphia, PA: Churchill Livingstone ; 2000: 1709-1714.
13. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 8 th ed. 2nd printing. Atlanta, GA: US Department of Health and Human Services, CDC ; 2005: 45-158.
14. Reef SE, Frey TK, Theall K., et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA. 2002 ; 287: 464-472.
15. Cooper LZ, Krugman S. Clinical manifestations of postnatal and congenital rubella. Arch Ophthalmol. 1967 ; 77: 434-439.
16. Glover B., Watkins S., Pittman P. SKI-HI home intervention for families with infants, toddlers, and preschool children who are deaf or hard of hearing. Infant-Toddler Intervent. 1994 ; 4: 320-321.
17. Barnett ED Infectious disease screening for refugees resettled in the United States. Clin Infect Dis. 2004 ; 39: 833-841.
18. Walker P., Jaranson J. Refugee and immigrant health care. Med Clin North Am. 1999 ; 83: 1103-1120.
19. International Organization for Migration. Health assessment for Africa. Available at: http://www.iom.int. Accessed March 9, 2005.
20. World Health Organization. Immunization surveillance, assessment, and monitoring. Available at: http://www.who.int/immunization_monitoring/. Accessed October 11, 2005.
21. Bolyard EA, Tablan OC, Williams WW, et al. Guideline for infection control in health care personnel; CDC personnel health guideline. Am J Infect Cont. 1998 ; 26: 291-354.